Co-Diagnostics, Inc. (CODX) P/E Ratio History
Deep ValueTrading at -0.0x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2020–2022
Loading P/E history...
P/E Ratio Analysis
As of November 8, 2026, Co-Diagnostics, Inc. (CODX) trades at a price-to-earnings ratio of -0.0x, with a stock price of $0.26 and trailing twelve-month earnings per share of $-10.92.
The current P/E is 100% below its 5-year average of 13.0x. Over the past five years, CODX's P/E has ranged from a low of 4.8x to a high of 66.5x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 24.6x, CODX trades at a 100% discount to its sector peers. The sector includes 242 companies with P/E ratios ranging from 0.0x to 196.0x.
Relative to the broader market, CODX trades at a notable discount to the S&P 500 median P/E of 21.8x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our CODX DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
CODX Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
CODX P/E vs Peers
Diagnostic Instruments & Tests peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $2B | 216.1 | - | -94% | |
| $53B | 45.2 | 3.17Best | +23%Best | |
| $258B | 36.4Lowest | 17.23 | +7% | |
| $162B | 37.6 | - | -5% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
CODX Historical P/E Data (2020–2022)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2022 Q3 | Sep 30 2022 | $96.30 | $13.83 | 7.0x | -47% |
| FY2022 Q2 | - | $168.30 | $26.63 | 6.3x | -52% |
| FY2022 Q1 | - | $185.40 | $39.01 | 4.8x | -64% |
| FY2021 Q4 | Dec 31 2021 | $267.90 | $36.79 | 7.3x | -44% |
| FY2021 Q3 | - | $291.90 | $43.09 | 6.8x | -48% |
| FY2021 Q2 | Jun 30 2021 | $247.50 | $47.50 | 5.2x | -60% |
| FY2021 Q1 | Mar 31 2021 | $286.20 | $53.04 | 5.4x | -59% |
| FY2020 Q4 | - | $279.00 | $43.74 | 6.4x | -51% |
| FY2020 Q3 | Sep 30 2020 | $407.70 | $27.66 | 14.7x | +13% |
| FY2020 Q2 | - | $580.50 | $8.73 | 66.5x | +410% |
Average P/E for displayed period: 13.0x
CODX Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
6+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CODX — Frequently Asked Questions
Quick answers to the most common questions about buying CODX stock.
What is CODX's P/E ratio?
Co-Diagnostics, Inc. (CODX) trailing twelve-month P/E ratio is -0.0x, based on TTM diluted EPS of $-10.92. The 5-year average P/E is 13.0x and the historical range spans 4.8x to 66.5x.
Is CODX stock overvalued or undervalued?
CODX current P/E: -0.0x. 5-year average P/E: 13.0x. Percentile: 0th.
Is CODX stock expensive?
CODX is fairly valued relative to its own history. The current P/E of -0.0x is near the 5-year average of 13.0x (0th percentile of historical range).
What is CODX's historical P/E range?
Over the past 5 years, CODX's P/E ratio has ranged from 4.8x to 66.5x, with a median of 6.8x and an average of 13.0x. The current P/E of -0.0x places the stock at the 0th percentile of this range. Full historical data spans 2020–2022.
How does CODX's P/E compare to the S&P 500?
CODX current P/E: -0.0x. S&P 500 median P/E: 21.8x.
How does CODX's valuation compare to Healthcare peers?
Co-Diagnostics, Inc. P/E of -0.0x can be benchmarked against Healthcare peers in the comparison table on this page.
What is CODX's PEG ratio?
CODX PEG ratio is N/A, based on a P/E of -0.0x and EPS growth of 5.2%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is CODX's earnings yield?
CODX earnings yield is N/A, the inverse of its -0.0x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.